Uterine serous cancer constitutes up to 10% of all endometrial tumors, and represents the most biologically aggressive variant of type II EC. This article will describe the most salient molecular ...

Expert Rev Anticancer Ther. 2012;12(1):41-49. Uterine serous cancer (USC) is a highly aggressive variant of endometrial cancer. USC is resistant to cytotoxic chemotherapy and is responsible for ...